---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-020477"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T03:40:12.948311+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Ardelyx appoints Merdad Parsey to Board of Directors, effective April 28, 2025

## Summary
- Merdad Parsey, M.D., Ph.D., appointed as Class I director, effective April 28, 2025.
- Also appointed to Nominating and Corporate Governance Committee effective June 18, 2025.
- Initial equity compensation: option and RSUs each valued at ~$225,000, plus annual cash retainers of $50k (board) and $5k (committee).
- Dr. Parsey is independent per Nasdaq Listing Rule 5605.

## SEC filing metadata
- accession: 0001628280-25-020477
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000162828025020477/0001628280-25-020477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000162828025020477/ardx-20250428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-020477
- JSON: https://secwatch.observer/filing/0001628280-25-020477.json
- Plain text: https://secwatch.observer/filing/0001628280-25-020477.txt

## Key facts
- Executive change
  Merdad Parsey was appointed as Director at ARDELYX, INC..
  - Action: appointed
  - Role: Director
  source text: On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the “Board”) of Ardelyx, Inc., a Delaware corporation (the “Company”), effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1437402/000162828025020477/0001628280-25-020477-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.